Charles S Fermaintt
3PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 11, 2022
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models.Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson
|Jul 02, 2021
Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential.Charles S Fermaintt, Thilini Peramuna, Shengxin Cai
|Feb 23, 2021
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake
Pageof 1
Frequent Collaborators
3 joint publications
April L Risinger
2 joint publications
Susan L Mooberry
1 joint publications
Susan Matthew
1 joint publications
Qi-Yin Chen
1 joint publications
Ranjala Ratnayake
1 joint publications
Daniel Lucena-Agell
1 joint publications
Seok Ting Lim
1 joint publications
Xiaomeng Wang
1 joint publications
J Fernando Díaz
1 joint publications
Valerie J Paul
